Myasthenic crisis is a life-threatening complication of myasthenia gravis. It’s when the muscles that you use to breathe get so weak that you can’t get air in and out of your lungs.

It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Revenue Growth: Over the 3 months period, Catalyst ...

The χ 2 test was used to compare mutant alleles with normal control alleles. Mutations in various genes of the neuromuscular junction cause congenital myasthenic syndromes (CMS). The protein rapsyn is ...

CHCH-TV started broadcasting in 1954 and is proud to be the news leader for Hamilton and the surrounding Halton and Niagara regions.

The Muscular Dystrophy Association (MDA)’s Kickstart program has announced receipt of both U.S. orphan drug and rare pediatric disease designations in support of work for congenital myasthenic ...

Truist Financial analyst Joon Lee reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report) today and set a price target of ...

Oppenheimer analyst Leland Gershell maintained a Buy rating on Catalyst Pharma (CPRX – Research Report) today and set a price target of ...

The first project within the MDA Kickstart program is focused on congenital myasthenic syndrome due to mutations in the choline acetyltransferase gene (CHAT) and likely affects less than 250 people in ...

Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse ...

Clinical features were similar at presentation for seropositive and seronegative patients, but MuSK positive patients frequently developed myasthenic crises. Despite the similar clinical severities at ...

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic ...

How Is Myasthenia Gravis Diagnosed? During a physical exam for myasthenia gravis, your health care provider may look for signs such as a droopy eyelid, difficulty holding your arms out at shoulder ...